{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:34:56Z","timestamp":1765805696810,"version":"3.40.4"},"reference-count":9,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T00:00:00Z","timestamp":1359936000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0022215112003210_sec1\"><jats:title>Background and objective:<\/jats:title><jats:p>Cutaneous anthrax usually has a mortality rate of less than 1 per cent. However, since December 2009 there have been more than 13 deaths in the UK due to anthrax-contaminated heroin. We therefore wish to raise clinical awareness of this treatable disease.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215112003210_sec2\"><jats:title>Case report:<\/jats:title><jats:p>We describe the case of a heroin user with an equivocal presentation of cellulitis in the neck. Within 36 hours, this led to death due to cutaneous anthrax.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215112003210_sec3\"><jats:title>Conclusion:<\/jats:title><jats:p>Whilst cutaneous anthrax remains rare, this case report aims to raise awareness of the fact that the symptoms and signs of this condition in intravenous drug users may not always fit the typical picture.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0022215112003210","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T15:13:40Z","timestamp":1359990820000},"page":"423-425","source":"Crossref","is-referenced-by-count":6,"title":["Fatal cutaneous anthrax in a heroin user"],"prefix":"10.1017","volume":"127","author":[{"given":"S","family":"Meghji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Judd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2013,2,4]]},"reference":[{"key":"S0022215112003210_ref9","doi-asserted-by":"publisher","DOI":"10.2807\/ese.15.02.19465-en"},{"key":"S0022215112003210_ref8","first-page":"21","article-title":"Clinical foundations for the use of methadone in patients with infectious diseases","volume":"12","author":"Somaini","year":"2010","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"S0022215112003210_ref6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0022-3565(24)37665-7","article-title":"Alterations of immune functions in heroin addicts and heroin withdrawal subjects","volume":"286","author":"Govitrapong","year":"1998","journal-title":"J Pharm Exp Ther"},{"key":"S0022215112003210_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2008.03.003"},{"key":"S0022215112003210_ref3","doi-asserted-by":"publisher","DOI":"10.1086\/510859"},{"key":"S0022215112003210_ref2","unstructured":"Medscape. Anthrax. In: http:\/\/emedicine.medscape.com\/article\/212127-overview [1 September 2010]"},{"key":"S0022215112003210_ref1","unstructured":"Health Protection Scotland. Interim Clinical Guidance for Management of Suspected Anthrax in Drug Users. In: http:\/\/www.hps.scot.nhs.uk\/anthrax\/documents\/clinical-guidance-for-use-of-anthrax-immune-globulin-v12-1-2010-03-19.pdf [1 September 2010]"},{"key":"S0022215112003210_ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-006-9029-z"},{"key":"S0022215112003210_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2005.12.018"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022215112003210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T19:27:36Z","timestamp":1745954856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022215112003210\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0022215112003210"],"URL":"https:\/\/doi.org\/10.1017\/s0022215112003210","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"type":"print","value":"0022-2151"},{"type":"electronic","value":"1748-5460"}],"subject":[],"published":{"date-parts":[[2013,2,4]]}}}